CURE Pharmaceutical Q2 2021 Revenue Spikes 700% After Increased Sales From Sera Labs Products Including A CVS Deal
Pharmaceutical company CURE Pharmaceutical Holding Corp. (OTC: CURR) announced earnings results on Tuesday for the quarter ended June 30, revealing revenue of $2.1 million. That's a year-over-year increase of 700%.
